AXSM vs BFLY
Axsome Therapeutics, Inc. vs Butterfly Network, Inc. — AI-powered side-by-side comparison
AXSM
Axsome Therapeutics, Inc.
55
Watch
VS
BFLY
Butterfly Network, Inc.
67
Buy
| Metric | AXSM | BFLY |
|---|
| AI Score |
55
|
67
|
| Price |
$215.92
|
$9.36
|
| P/E Ratio |
-57.54×
|
-32.38×
|
| ROE |
-207.5%
|
-39.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
93.2%
|
51.1%
|
| Debt / Equity |
2.63×
|
0.10×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
41.5
|
66.4
|
| Beta |
0.596
|
2.084
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for AXSM versus BFLY.
BFLY leads by 12 points.
BFLY scores 67/100 (Buy) versus AXSM at 55/100 (Watch).
AXSM Committee View
50% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 20.4% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 20.4% signals elevated volatility — Risk
BFLY Committee View
67% agreement
6 analysts
The primary driver is revenue growing 28.1% yoy -- genuine top-line momentum. The main limiting factor is roe of only -38.4% -- cheap may mean cheap for a reason. The committee is constructive but not yet at full conviction.
Bull Case
- Revenue growing 28.1% YoY -- genuine top-line momentum — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- ROE of only -38.4% -- cheap may mean cheap for a reason — Value
- Bollinger bandwidth of 52.6% signals elevated volatility — Risk